Er Nie

1.1k total citations
22 papers, 852 citations indexed

About

Er Nie is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Er Nie has authored 22 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Cancer Research and 6 papers in Genetics. Recurrent topics in Er Nie's work include MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (7 papers) and Glioma Diagnosis and Treatment (6 papers). Er Nie is often cited by papers focused on MicroRNA in disease regulation (12 papers), Cancer-related molecular mechanisms research (7 papers) and Glioma Diagnosis and Treatment (6 papers). Er Nie collaborates with scholars based in China. Er Nie's co-authors include Tianfu Yu, Tongle Zhi, Yingyi Wang, Junxia Zhang, Yongping You, Weining Wu, Kuan Jiang, Ning Liu, Xiefeng Wang and Xu Zhou and has published in prestigious journals such as Cancer Research, Oncogene and Scientific Reports.

In The Last Decade

Er Nie

22 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Er Nie China 18 694 578 118 69 62 22 852
Tongle Zhi China 20 767 1.1× 602 1.0× 113 1.0× 87 1.3× 73 1.2× 28 957
Rut Tejero Spain 16 593 0.9× 463 0.8× 113 1.0× 105 1.5× 54 0.9× 24 788
Kara M. Foshay United States 12 446 0.6× 257 0.4× 104 0.9× 92 1.3× 66 1.1× 15 652
Bakhos A. Tannous United States 6 825 1.2× 777 1.3× 72 0.6× 55 0.8× 28 0.5× 6 991
Paula Aldaz Spain 12 373 0.5× 260 0.4× 139 1.2× 145 2.1× 46 0.7× 16 549
Hai Yu China 16 565 0.8× 446 0.8× 67 0.6× 162 2.3× 82 1.3× 31 792
Zihang Chen China 13 625 0.9× 488 0.8× 93 0.8× 89 1.3× 264 4.3× 19 827
Aayushi Mahajan United States 8 336 0.5× 174 0.3× 165 1.4× 67 1.0× 48 0.8× 19 518
A. Maghnouj Germany 6 643 0.9× 627 1.1× 48 0.4× 203 2.9× 29 0.5× 8 855
Hye-Min Jeon South Korea 10 332 0.5× 236 0.4× 135 1.1× 192 2.8× 62 1.0× 10 544

Countries citing papers authored by Er Nie

Since Specialization
Citations

This map shows the geographic impact of Er Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Er Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Er Nie more than expected).

Fields of papers citing papers by Er Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Er Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Er Nie. The network helps show where Er Nie may publish in the future.

Co-authorship network of co-authors of Er Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Er Nie. A scholar is included among the top collaborators of Er Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Er Nie. Er Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Shuping, et al.. (2024). SRBD1 Regulates the Cell Cycle, Apoptosis, and M2 Macrophage Polarization via the RPL11‐MDM2‐p53 Pathway in Glioma. Environmental Toxicology. 40(1). 66–78. 1 indexed citations
2.
Nie, Er, et al.. (2022). MEX3A Impairs DNA Mismatch Repair Signaling and Mediates Acquired Temozolomide Resistance in Glioblastoma. Cancer Research. 82(22). 4234–4246. 17 indexed citations
3.
Wang, Yan, Xiang Wang, Xu Wang, et al.. (2021). Imipramine impedes glioma progression by inhibiting YAP as a Hippo pathway independent manner and synergizes with temozolomide. Journal of Cellular and Molecular Medicine. 25(19). 9350–9363. 19 indexed citations
4.
Nie, Er, Xin Jin, Tianfu Yu, et al.. (2020). TGF-β1 modulates temozolomide resistance in glioblastoma via altered microRNA processing and elevated MGMT. Neuro-Oncology. 23(3). 435–446. 60 indexed citations
5.
Dong, Liang, Tong Zhang, Er Nie, et al.. (2019). Effects of Long Form of CAPON Overexpression on Glioma Cell Proliferation are Dependent on AKT/mTOR/P53 Signaling. International Journal of Medical Sciences. 16(4). 614–622. 5 indexed citations
6.
Nie, Er, Xin Jin, Weining Wu, et al.. (2018). Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma. Oncogene. 38(15). 2706–2721. 37 indexed citations
7.
Yu, Tianfu, Xiefeng Wang, Tongle Zhi, et al.. (2018). Delivery of MGMT mRNA to glioma cells by reactive astrocyte-derived exosomes confers a temozolomide resistance phenotype. Cancer Letters. 433. 210–220. 82 indexed citations
8.
Zeng, Ailiang, Wei Yan, Zheng Wang, et al.. (2017). Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene. 36(38). 5369–5381. 100 indexed citations
9.
Jin, Xin, Er Nie, Xu Zhou, et al.. (2017). Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway. Cellular Physiology and Biochemistry. 44(4). 1616–1628. 26 indexed citations
10.
Hu, Qi, Weining Wu, Ailiang Zeng, et al.. (2017). Polycomb group expression signatures in the malignant progression of gliomas. Oncology Letters. 13(4). 2583–2590. 3 indexed citations
11.
Wang, Yingyi, Tianfu Yu, Er Nie, et al.. (2017). Blocking MIR155HG/miR-155 axis inhibits mesenchymal transition in glioma. Neuro-Oncology. 19(9). 1195–1205. 109 indexed citations
12.
Wu, Weining, Qi Hu, Er Nie, et al.. (2017). Hypoxia induces H19 expression through direct and indirect Hif-1α activity, promoting oncogenic effects in glioblastoma. Scientific Reports. 7(1). 45029–45029. 106 indexed citations
13.
Wu, Weining, Xu Zhou, Tianfu Yu, et al.. (2017). The malignancy of miR-18a in human glioblastoma via directly targeting CBX7.. PubMed. 7(1). 64–76. 22 indexed citations
14.
Nie, Er, Xin Jin, Weining Wu, et al.. (2017). MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT. Journal of Neuro-Oncology. 133(1). 59–68. 37 indexed citations
15.
Zhou, Xu, Weining Wu, Ailiang Zeng, et al.. (2017). MicroRNA-141-3p promotes glioma cell growth and temozolomide resistance by directly targeting p53. Oncotarget. 8(41). 71080–71094. 45 indexed citations
16.
Yu, Tianfu, Youzhi Wu, Qi Hu, et al.. (2017). CBX7 is a glioma prognostic marker and induces G1/S arrest via the silencing of CCNE1. Oncotarget. 8(16). 26637–26647. 23 indexed citations
17.
Zhi, Tongle, Kuan Jiang, Xiupeng Xu, et al.. (2017). MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.. PubMed. 9(11). 4872–4887. 32 indexed citations
18.
Jiang, Kuan, Tongle Zhi, Wenhui Xu, et al.. (2017). MicroRNA-1468-5p inhibits glioma cell proliferation and induces cell cycle arrest by targeting RRM1.. PubMed. 7(4). 784–800. 19 indexed citations
19.
Nie, Er, Xin Jin, Weining Wu, et al.. (2016). BACH1 Promotes Temozolomide Resistance in Glioblastoma through Antagonizing the Function of p53. Scientific Reports. 6(1). 39743–39743. 32 indexed citations
20.
Zhi, Tongle, Er Nie, Xuebin Xu, et al.. (2014). Bex2 Controls Proliferation of Human Glioblastoma Cells Through NF-κB Signaling Pathway. Journal of Molecular Neuroscience. 53(2). 262–270. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tongle Zhi Breakdown of academic impact, for papers by Rut Tejero Breakdown of academic impact, for papers by Kara M. Foshay Breakdown of academic impact, for papers by Bakhos A. Tannous Breakdown of academic impact, for papers by Paula Aldaz Breakdown of academic impact, for papers by Hai Yu Breakdown of academic impact, for papers by Zihang Chen Breakdown of academic impact, for papers by Aayushi Mahajan Breakdown of academic impact, for papers by A. Maghnouj Breakdown of academic impact, for papers by Hye-Min Jeon
Rankless by CCL
2026